Advertisement

Akutes Leberversagen

  • K. H. W. Böker
  • M. P. Manns
Chapter
  • 77 Downloads

Zusammenfassung

Als akutes Leberversagen bezeichnet man den Ausfall der Leberfunktion bei Patienten, die vorher keine chronische Leberkrankheit hatten.

Literatur

  1. 1.
    Aggarwal S, Kramer D, Yonas H et al. (1994) Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology 19: 80–87PubMedCrossRefGoogle Scholar
  2. 2.
    Berman DH, Leventhal RI, Gavaler JS et al. (1991) Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 100: 1129–1134PubMedGoogle Scholar
  3. 3.
    Bismuth H, Samuel D, Castaing D et al. (1996) Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 16: 415–425PubMedCrossRefGoogle Scholar
  4. 4.
    Blei AT, Olafsson S, Webster Set al. (1993) Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 341: 157–158PubMedCrossRefGoogle Scholar
  5. 5.
    Devlin J, Ellis AE, McPeake J et al. (1997) N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med 25: 236–242PubMedCrossRefGoogle Scholar
  6. 6.
    Ellis A, Wendon J (1996) Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis 16: 379–388PubMedCrossRefGoogle Scholar
  7. 7.
    Fiaccadori F, Pedretti G, Ferrari C et al. (1991) Insulin and glucagon levels in fulminant hepatic failure in man. Dig Dis Sci 36: 801808Google Scholar
  8. 8.
    Gimson A, Tedder R, White Y (1983) Serological markers in fulminant Hepatitis B. Gut 24: 615PubMedCrossRefGoogle Scholar
  9. 9.
    Gubernatis G, Pichlmayr R, Kemnitz J et al. (1991) Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg 15: 660–605PubMedCrossRefGoogle Scholar
  10. 10.
    Gyr K, Meier R (1991) Flumazenil in the treatment of portal systemic encephalopathy–an overview. Intensive Care Med 17 (Suppl 1): 39–42CrossRefGoogle Scholar
  11. 11.
    Häussinger D, Laubenberger J, vom Dahl S et al. (1994) Proton magnetic resonance spectroscopy studies on human brain myoinositol in hyperosmolarity and hepatic encephalopathy. Gastroenterology 107: 1475–1480PubMedCrossRefGoogle Scholar
  12. 12.
    Krowka MJ (1993) Clinical management of hepatopulmonary syndrome. Sem Liver Dis 13: 414–422CrossRefGoogle Scholar
  13. 13.
    Lake JR, Sussman NL (1995) Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answer [editorial]. Hepatology 21: 879–882PubMedCrossRefGoogle Scholar
  14. 14.
    Lee WM (1996) Management of acute liver failure. Semin Liver Dis 16: 369–378PubMedCrossRefGoogle Scholar
  15. 15.
    Liang TJ, Hasegawa K, Rimon N et al. (1991) A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 324: 1705–1709PubMedCrossRefGoogle Scholar
  16. 16.
    McConnel JR, Antonson DL, Ong CS et al. (1995) Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 22: 69–74CrossRefGoogle Scholar
  17. 17.
    McGuire BM, Sielaff TD, Nyberg SL et al. (1995) Review of support systems used in the management of fulminant hepatic failure. Dig Dis 13: 379–388PubMedCrossRefGoogle Scholar
  18. 18.
    Munoz SJ (1993) Difficult management problems in fulminant hepatic failure. Semin Liver Dis 13: 395–413PubMedCrossRefGoogle Scholar
  19. 19.
    O’GradyJG (1997) Paracetamol hepatotoxicity: how to prevent.J R Soc Med 90: 368–370Google Scholar
  20. 20.
    Pereira LM, Langley PG, Hayllar KM et al. (1992) Coagulation factor V and VIIIN ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut 33: 98–102PubMedCrossRefGoogle Scholar
  21. 21.
    Pereira SP, Langley PG, Williams R (1996) The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 16: 403–414PubMedCrossRefGoogle Scholar
  22. 22.
    Pohl L (1990) Drug induced allergic hepatitis. Semin Liver Dis 10: 305–315PubMedCrossRefGoogle Scholar
  23. 23.
    Riely CA (1994) Hepatic disease in pregnancy. Am J Med 96:18 S-22 SGoogle Scholar
  24. 24.
    Stremmel W, Meyerrose KW, Niederau C et al. (1991) Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 11: 720–726CrossRefGoogle Scholar
  25. 25.
    Theilmann L, Solbach C,Toex U et al. (1992) Role of hepatitis C virus infection in German patients with fulminant and subacute hepatic failure. Eur J Clin Invest 22: 569–571PubMedCrossRefGoogle Scholar
  26. 26.
    Van Pelt F, Straub P, Manns M (1995) Molecular basis of drug induced immunological liver injury. Semin Liver Dis 15: 283–300PubMedCrossRefGoogle Scholar
  27. 27.
    Williams R (1996) Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 16: 343–348PubMedCrossRefGoogle Scholar
  28. 28.
    Williams R, Wendon J (1994) Indications for orthotopic liver transplantation in fulminant liver failure. Hepatology 20: 5–10CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • K. H. W. Böker
  • M. P. Manns

There are no affiliations available

Personalised recommendations